hyaluronic acid

Case Series

Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection

11/01/2022

Xin Wang

Qiming Zhao

Xiaoping Chen

Xiaowei Wang

Miao Wang

Xiaoxiang Huang

Xiaohui Long

Yue Chen

Twelve patients who experienced facial tissue necrosis as a result of hyaluronic acid injection were treated with injections of concentrated growth factor, and the complete healing rate at 4 weeks was 91.67%.

Twelve patients who experienced...

11/01/2022

Wounds

Evidence Corner

Improving Venous Ulcer Outcomes

03/31/2022

Laura Bolton

This month’s Evidence Corner summarizes recent randomized clinical trials documenting healing effects of topical gauze dressings impregnated with hyaluronic acid or placebo cream as an adjunct to patient-appropriate compression or low-level...

This month’s Evidence Corner...

03/31/2022

Wounds

Original Research

Efficacy and Safety of a Hyaluronic Acid–Containing Cream in the Treatment of Chronic, Venous, or Mixed-Origin Leg Ulcers: A Prospective, Multicenter Randomized Controlled Trial

10/05/2021

Jacek Mikosinski

Anna Di Landro

Karolina Kasztalska-Kazmierczak

Emilie Soriano

Carol Caverzasio

Daniela Binelli

Bruno Falissard

Olivier Dereure

This study compared the efficacy and safety of topical application of a hyaluronic acid cream vs a neutral comparator (identical cream without HA) in treating subjects with chronic leg ulcers of vascular origin.

This study compared the efficacy...

10/05/2021

Wounds

Original Research

Efficacy and Safety of a Hyaluronic Acid-Containing Gauze Pad in the Treatment of Chronic Venous or Mixed-Origin Leg Ulcers: A Prospective, Multicenter, Randomized Controlled Trial

06/07/2021

Jacek Mikosinski

Anna Di Landro

Krzysztofa Łuczak-Szymerska

Emilie Soriano

Carol Caverzasio

Daniela Binelli

Bruno Falissard

Olivier Dereure

This study compared an HA-impregnated gauze pad with a gauze pad without HA.

This study compared an...

06/07/2021

Wounds

Limb Salvage in Non-Compliant Type II Diabetic Patients using an Esterified Hyaluronic Acid Matrix without Split Thickness Skin Graft (STSG)

Introduction: The incidence of type II diabetes has increased to 8.6% representing nearly 21 million people in the US alone (1). As many as 15% of diabetic patients will develop lower ex...

01/28/2021

Treatment of Chronic Lower Extremity Wounds in Diabetic Patients Using an Esterified Hyaluronic Acid Matrix

Abstract Body: Lower extremity wounds largely consist of venous leg ulcers and diabetic foot ulcers. Many are the result of traumatic leg injuries, peripheral arterial disease or infectio...

11/23/2020